...
机译:P1.02-040多焦肺腺癌中EGFR / KRA基因突变的异质性及临床意义
Department of Pathology Cancer Hospital Chinese Academy of Medical Sciences;
State Key Laboratory of Molecular Oncology Cancer Hospital Chinese Academy of Medical Sciences;
State Key Laboratory of Molecular Oncology Cancer Hospital Chinese Academy of Medical Sciences;
Department of Pathology Cancer Hospital Chinese Academy of Medical Sciences;
State Key Laboratory of Molecular Oncology Cancer Hospital Chinese Academy of Medical Sciences;
机译:P1.02-040多焦肺腺癌中EGFR / KRA基因突变的异质性及临床意义
机译:在外显子19和21上发生EGFR突变的肺腺癌患者中EGFR-TKI治疗的临床结果和遗传异质性
机译:在外显子19和21上发生EGFR突变的肺腺癌患者中EGFR-TKI治疗的临床结果和遗传异质性
机译:接受酪氨酸激酶抑制剂治疗的EGFR突变非小细胞肺癌患者肿瘤异质性与无进展生存的关系
机译:遗传和环境对小鼠Kras驱动的肺癌的突变景观的影响。
机译:EGFR-TKI治疗的临床结果和外源19和21外显子EGFR突变的肺腺癌患者的遗传异质性
机译:没有肺腺癌的瘤内异质性的韩国男性吸烟者中EGFR突变的高发病率:与组织学亚型,EGFR / TTF-1表达和临床特征的关系